Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Transplantation Proceedings|November 22, 2011
Instant blood-mediated inflammatory reaction during islet transplantation: the role of Toll-like receptors signaling pathwaysK Vivot, A Langlois, N Jeandidier, et al.
Minerva Endocrinologica|July 9, 2014
Substitution of insulin by exenatide in bad controlled type 2 diabetic patients: efficacy and predictive factorsM Barthélémy, S Boullu Sanchis, F Moreau, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 31, 2001
High antigenicity of intraperitoneal insulin infusion via implantable devices: preliminary rat studiesN Jeandidier, S Boullu, E Delatte, et al.
Diabetes & Metabolism|September 16, 2006
Efficacy of short term continuous subcutaneous insulin lispro versus continuous intravenous regular insulin in poorly controlled, hospitalized, type 2 diabetic patientsS Boullu-Sanchis, F Ortega, G Chabrier, et al.
Diabetes Care|September 22, 2009
Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend studyDenis Raccah, Véronique Sulmont, Yves Reznik, et al.
Diabetes Care|January 5, 2002
Comparison of antigenicity of Hoechst 21PH insulin using either implantable intraperitoneal pump or subcutaneous external pump infusion in type 1 diabetic patientsNathalie Jeandidier, Sylvie Boullu, Marie-Sophie Busch-Brafin, et al.
Fetal Diagnosis and Therapy|November 5, 2023
Trisomy 22: First and Second Trimester Cytogenetic Analysis and Phenotypic Presentation in a Series of Seven CasesChris Minella, Eric Jeandidier, Antoine Koch, et al.
Cell Transplantation|June 15, 2023
Beneficial Effects of Two Marine Oxygen Carriers, M101 and M201, on Human Islet Quality in Hypoxic Culture ConditionsFlorent Lemaire, Séverine Sigrist, Jonathan Brassard, et al.
Diabetologia|May 1, 1995
Immunogenicity of intraperitoneal insulin infusion using programmable implantable devicesN Jeandidier, S Boivin, R Sapin, et al.
Diabetes Care|March 1, 1995
Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. The EVADIAC Study Group. Evaluation dans le Diabète du Traitement par Implants ActifsH Hanaire-Broutin, C Broussolle, N Jeandidier, et al.
Pageof 13